Patent details

Basic Information

Publication number:

EP1109576

PCT Application Number:

PCT/US/1999/018982

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP999451156

PCT Publication Number:

WO/2000/010599

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IMMUNOGENIC BETA-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE

French Title of Invention:

CONJUGUE DE PROTEINE-POLYSACCHARIDE IMMUNOGENE A LIAISON BETA-PROPIONAMIDO, UTILE COMME VACCIN ETABLI AU MOYEN D'UN POLYSACCHARIDE N-ACRYLOYLE

German Title of Invention:

IMMUNOGENES BETA-PROPIONAMIDO-GEBUNDENES POLYSACCHARID-PROTEIN KONJUGAT GEEIGNET ALS IMPFSTOFF UND HERGESTELLT BEI VERWENDUNG VON N-ACRYLOYLIERTEM POLYSACCHARID

SPC Number:

Dates

Filing date:

18/08/1999

Grant date:

21/10/2009

EP Publication Date:

21/10/2009

PCT Publication Date:

02/03/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/06/2001

EP B1 Publication Date:

21/10/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/08/2010

Expiration date:

18/08/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/08/1999

 

 

Name:

Baxter Healthcare SA

Address:

Hertistrasse 2, 8306 Wallisellen, Switzerland (CH)

Inventor

1

Name:

UITZ Catherine

Address:

United States (US)

2

Name:

MICHON Francis

Address:

United States (US)

3

Name:

HUANG Chun-Hsien

Address:

United States (US)

Priority

1

Priority Number:

97120 P

Priority Date:

19/08/1998

Priority Country:

United States (US)

2

Priority Number:

376911

Priority Date:

18/08/1999

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/385;

Filing date	Document type	Number of pages